Pfizer Inc (PFE)
28.16
+0.35
(+1.26%)
USD |
NYSE |
May 06, 16:00
28.22
+0.06
(+0.21%)
Pre-Market: 07:22
Pfizer Accounts Payable (Quarterly): 6.71B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.71B |
September 30, 2023 | 5.338B |
June 30, 2023 | 6.081B |
March 31, 2023 | 6.123B |
December 31, 2022 | 6.809B |
September 30, 2022 | 6.267B |
June 30, 2022 | 6.208B |
March 31, 2022 | 5.506B |
December 31, 2021 | 5.578B |
September 30, 2021 | 4.698B |
June 30, 2021 | 4.327B |
March 31, 2021 | 4.064B |
December 31, 2020 | 4.283B |
September 30, 2020 | 4.141B |
June 30, 2020 | 3.872B |
March 31, 2020 | 3.972B |
December 31, 2019 | 3.887B |
September 30, 2019 | 3.942B |
June 30, 2019 | 4.002B |
March 31, 2019 | 4.156B |
December 31, 2018 | 4.674B |
September 30, 2018 | 4.297B |
June 30, 2018 | 4.196B |
March 31, 2018 | 3.879B |
December 31, 2017 | 4.656B |
Date | Value |
---|---|
September 30, 2017 | 3.48B |
June 30, 2017 | 3.439B |
March 31, 2017 | 3.393B |
December 31, 2016 | 4.536B |
September 30, 2016 | 3.476B |
June 30, 2016 | 3.261B |
March 31, 2016 | 3.125B |
December 31, 2015 | 3.62B |
September 30, 2015 | 3.294B |
June 30, 2015 | 2.93B |
March 31, 2015 | 2.724B |
December 31, 2014 | 3.21B |
September 30, 2014 | 2.973B |
June 30, 2014 | 2.99B |
March 31, 2014 | 2.546B |
December 31, 2013 | 3.234B |
September 30, 2013 | 2.287B |
June 30, 2013 | 1.978B |
March 31, 2013 | 3.279B |
December 31, 2012 | 2.921B |
September 30, 2012 | 2.967B |
June 30, 2012 | 3.165B |
March 31, 2012 | 3.091B |
December 31, 2011 | 3.678B |
September 30, 2011 | 3.765B |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
3.872B
Minimum
Jun 2020
6.809B
Maximum
Dec 2022
5.043B
Average
4.698B
Median
Sep 2021
Accounts Payable (Quarterly) Benchmarks
Amgen Inc | 1.628B |
Johnson & Johnson | 8.174B |
Eli Lilly and Co | 2.474B |
Viking Therapeutics Inc | 5.225M |
Moderna Inc | 183.00M |